US BANCORP \DE\ - BIOSPECIFICS TECHNOLOGIES CO ownership

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$31,000
-16.2%
5940.0%0.00%
Q2 2020$37,0000.0%594
-7.8%
0.00%
Q1 2020$37,000
-31.5%
644
-31.7%
0.00%
Q4 2019$54,000
+8.0%
9430.0%0.00%
Q3 2019$50,000
-13.8%
943
-2.6%
0.00%
Q2 2019$58,000
-39.6%
968
-37.3%
0.00%
Q1 2019$96,000
-17.2%
1,544
-18.8%
0.00%
Q4 2018$116,000
-11.5%
1,902
-15.0%
0.00%
Q3 2018$131,000
+17.0%
2,237
-10.1%
0.00%
Q2 2018$112,000
+1.8%
2,487
+0.4%
0.00%
Q1 2018$110,000
-12.0%
2,478
-14.7%
0.00%
Q4 2017$125,000
-17.8%
2,904
-11.1%
0.00%
Q3 2017$152,000
-11.1%
3,266
-5.5%
0.00%
-100.0%
Q2 2017$171,000
-9.0%
3,455
+1.1%
0.00%0.0%
Q1 2017$188,000
-4.1%
3,419
-3.0%
0.00%0.0%
Q4 2016$196,000
+24.1%
3,523
+1.5%
0.00%0.0%
Q3 2016$158,000
+30.6%
3,470
+14.7%
0.00%
Q2 2016$121,000
+39.1%
3,025
+21.0%
0.00%
Q1 2016$87,000
-15.5%
2,500
+4.7%
0.00%
Q4 2015$103,000
-5.5%
2,387
-5.0%
0.00%
Q3 2015$109,000
-17.4%
2,513
-2.1%
0.00%
-100.0%
Q2 2015$132,000
+33.3%
2,567
+1.8%
0.00%
Q1 2015$99,000
+2.1%
2,5210.0%0.00%
Q4 2014$97,000
+54.0%
2,521
+40.9%
0.00%
Q3 2014$63,000
+31.2%
1,7890.0%0.00%
Q2 2014$48,000
+4.3%
1,7890.0%0.00%
Q1 2014$46,000
+17.9%
1,7890.0%0.00%
Q4 2013$39,000
+8.3%
1,789
-2.6%
0.00%
Q3 2013$36,000
+24.1%
1,8360.0%0.00%
Q2 2013$29,0001,8360.00%
Other shareholders

There were no reported owners of BIOSPECIFICS TECHNOLOGIES CO in Q3 2023.

NameSharesValueWeighting ↓
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders